Search Results - "LEVY, Gary A"

Refine Results
  1. 1
  2. 2
  3. 3

    GITR intrinsically sustains early type 1 and late follicular helper CD4 T cell accumulation to control a chronic viral infection by Clouthier, Derek L, Zhou, Angela C, Wortzman, Michael E, Luft, Olga, Levy, Gary A, Watts, Tania H

    Published in PLoS pathogens (01-01-2015)
    “…CD4 T cells are critical for control of persistent infections; however, the key signals that regulate CD4 T help during chronic infection remain incompletely…”
    Get full text
    Journal Article
  4. 4

    Antiviral Treatment of Recurrent Hepatitis C After Liver Transplantation: Predictors of Response and Long-Term Outcome by SELZNER, Nazia, RENNER, Eberhard L, SELZNER, Markus, ADEYI, Oyedele, KASHFI, Arash, THERAPONDOS, George, GIRGRAH, Nigel, HERATH, Chaturika, LEVY, Gary A, LILLY, Leslie

    Published in Transplantation (27-11-2009)
    “…Efficacy and long-term outcome of antiviral therapy for recurrent hepatitis C after liver transplantation is poorly defined. This study aimed at assessing the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Protective effects of long pentraxin PTX3 on lung injury in a severe acute respiratory syndrome model in mice by Han, Bing, Ma, Xuezhong, Zhang, Jianhua, Zhang, Yu, Bai, Xiaohui, Hwang, David M, Keshavjee, Shaf, Levy, Gary A, McGilvray, Ian, Liu, Mingyao

    Published in Laboratory investigation (01-09-2012)
    “…The outbreak of severe acute respiratory syndrome (SARS) in 2003 reinforces the potential of lethal pandemics of respiratory viral infections. The underlying…”
    Get full text
    Journal Article
  7. 7

    Therapeutic drug monitoring of immunosuppressant drugs in clinical practice by Kahan, Barry D., Keown, Paul, Levy, Gary A., Johnston, Atholl

    Published in Clinical therapeutics (01-03-2002)
    “…Background: Therapeutic drug monitoring (TDM) is essential to maintain the efficacy of many immunosuppressant drugs while minimizing their toxicity. TDM has…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation by Chruscinski, Andrzej, Huang, Flora Y Y, Nguyen, Albert, Lioe, Jocelyn, Tumiati, Laura C, Kozuszko, Stella, Tinckam, Kathryn J, Rao, Vivek, Dunn, Shannon E, Persinger, Michael A, Levy, Gary A, Ross, Heather J

    Published in PloS one (11-03-2016)
    “…Autoantibodies directed against endogenous proteins including contractile proteins and endothelial antigens are frequently detected in patients with heart…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma by Sandroussi, Charbel, Dawson, Laura A, Lee, Mark, Guindi, Maha, Fischer, Sandra, Ghanekar, Anand, Cattral, Mark S, McGilvray, Ian D, Levy, Gary A, Renner, Eberhard, Greig, Paul D, Grant, David R

    Published in Transplant international (01-03-2010)
    “…About 20% of the patients with advanced hepatocellular carcinoma (HCC) who are listed for liver transplantation (LT) are eventually delisted as a result of…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Right lobe living-donor hepatectomy—the Toronto approach, tips and tricks by Sapisochin, Gonzalo, Goldaracena, Nicolas, Laurence, Jerome M., Levy, Gary A., Grant, David R., Cattral, Mark S.

    Published in Hepatobiliary surgery and nutrition (01-04-2016)
    “…Living-donor liver transplantation (LDLT) is a well-established treatment for end-stage liver disease. Nevertheless, it has not been extensively accepted in…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Recipient age affects long‐term outcome and hepatitis C recurrence in old donor livers following transplantation by Selzner, Markus, Kashfi, Arash, Selzner, Nazia, McCluskey, Stuart, Greig, Paul D., Cattral, Mark S., Levy, Gary A., Lilly, Les, Renner, Eberhard L., Therapondos, George, Adcock, Lesley E., Grant, David R., McGilvray, Ian D.

    Published in Liver transplantation (01-10-2009)
    “…We studied the role of donor and recipient age in transplantation/ischemia‐reperfusion injury (TIRI) and short‐ and long‐term graft and patient survival. Eight…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Endothelial Induction of fgl2 Contributes to Thrombosis during Acute Vascular Xenograft Rejection by Ghanekar, Anand, Mendicino, Michael, Liu, Hao, He, Wei, Liu, Mingfeng, Zhong, Robert, Phillips, M. James, Levy, Gary A, Grant, David R

    Published in The Journal of immunology (1950) (01-05-2004)
    “…Thrombosis is a prominent feature of acute vascular rejection (AVR), the current barrier to survival of pig-to-primate xenografts. Fibrinogen-like protein 2…”
    Get full text
    Journal Article
  19. 19

    Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants by Shah, Shimul A, Tan, Jensen C C, McGilvray, Ian D, Cattral, Mark S, Levy, Gary A, Greig, Paul D, Grant, David R

    Published in Journal of gastrointestinal surgery (01-04-2007)
    “…Macroscopic vascular invasion (macroVI) is associated with poor outcomes after liver transplantation (LT) for hepatocellular carcinoma (HCC). Whether…”
    Get full text
    Journal Article
  20. 20

    Genetic Determinants of Mouse Hepatitis Virus Strain 1 Pneumovirulence by Leibowitz, Julian L, Srinivasa, Rajiv, Williamson, Shawn T, Chua, Ming Ming, Liu, Mingfeng, Wu, Samantha, Kang, Hyojeung, Ma, Xue-Zhong, Zhang, Jianhua, Shalev, Itay, Smith, Robert, Phillips, Melville J, Levy, Gary A, Weiss, Susan R

    Published in Journal of Virology (15-09-2010)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article